There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.
The Supreme Court on Monday rejected a bid by notorious "pharma bro" Martin Shkreli to hear his appeal of a $64 million ...
The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 ...
The U.S. Supreme Court decided on Monday not to take up Martin Shkreli’s appeal of a $64.6 million penalty he received after ...
Martin Shkreli an order to return millions in profits he and his former company reaped after monopolizing the market for a ...
The U.S. Supreme Court on Monday rejected appeals from two high-profile figures: R&B singer R. Kelly, and former ...
The judge cited Shkreli’s “particularly heartless and coercive” tactics in monopolizing Daraprim and keeping generic rivals ...
The former pharmaceutical executive sought to appeal a $64.6 million judgement issued against him for inflating drug cost and ...
In the latest chapter in the legal battle over the Wu-Tang Clan’s Once Upon a Time in Shaolin, Martin Shkreli admitted he doesn’t know how many people have copies of the one-copy-only album.